Reach de-identified patient and provider segments at scale across every channel.
Pharmaceutical brands and media platforms, including connected TV (CTV), can activate HIPAA-compliant audiences built on real-world clinical and claims data through a new collaboration between PurpleLab and Experian.
Targeting de-identified audiences is essential for engaging the right patients at pivotal moments in their health journey, maximizing ROI while safeguarding privacy and improving outcomes. Overall, prescription drugmakers spent $2.97 billion on national TV advertising in the first half of 2025, a 12.2% year-over-year increase, underscoring the growing demand for scalable, privacy-compliant healthcare advertising in premium media environments.
Now, whether you’re a pharma advertiser launching a new therapy or a platform curating health-focused inventory, PurpleLab’s integration refreshes the media planning ecosystem, offering marketers easier access to the audiences needed to drive impact.
Activate with accuracy and scale
PurpleLab’s de-identified healthcare segments, categorized by condition, treatment, specialty, and prescription behavior, are now accessible through Experian’s data marketplace, streamlining media planning. This integration enables PurpleLab’s privacy-safe audiences to travel from discovery to omnichannel delivery. Experian then handles onboarding, activation, and audience expansion, in accordance with HIPAA and with industry standards.
Utilizing Experian’s identity graph, spanning household and individual-level insights, as well as marketing attributes, these healthcare audiences can be:
- Onboarded securely, matching hashed emails or tokens to digital identifiers
- Activated across major channels, including CTV, mobile, display, and social
- Expanded with confidence, reaching more of the target population, patients, or healthcare professionals, without relying on third-party cookies
This infrastructure unlocks greater scale and completeness for niche pharma audiences that have historically been hard to reach in digital and streaming environments. For brands navigating fragmented media and tightening privacy regulations, this collaboration provides the clarity and consistency they’ve been seeking.
“We know healthcare marketers are under pressure to get it right: to respect privacy, be accurate, and scale. That’s why we’re excited to bring PurpleLab audiences into the Experian data marketplace and make them available through Audigent’s curated deals. It gives pharmaceutical brands and platforms a clear way to plan and measure campaigns, with the assurance that they’re reaching patients and providers when it matters in the right way.”
ExperianKim Gilberti, General Manager
Curation through Audigent: Premium supply meets premium data
For advertisers seeking turnkey media solutions, PurpleLab audiences are now also available through Audigent’s curated deals. Audigent’s curated deals simplify media buying by packaging PurpleLab’s clinically grounded audiences with premium, brand-safe inventory, thus creating a unified package.
Instead of stitching together data and supply separately, media buyers can now access pre-built or custom-curated media deals where PurpleLab audiences are already integrated, ideal for health and wellness programming, premium CTV, or contextual content aligned to therapeutic areas. This approach gives marketers both efficiency and accuracy, streamlining execution while maintaining compliance and relevance.
“Bringing together PurpleLab’s clinically precise audiences with Experian’s powerful identity and activation capabilities, and pairing it with Audigent’s premium inventory, gives advertisers more than a turnkey solution. It’s the power to launch campaigns that truly resonate, with data and media working in harmony from day one to deliver both efficiency and impact.”
PurpleLabScott Ronay, VP, Advertising Sales
Real-world use cases: Accuracy with purpose
CTV awareness for cardiovascular therapies
A cardiovascular brand is launching a CTV campaign to reach healthcare providers involved in treatment decisions. Using PurpleLab’s provider-level segments from the Experian data marketplace, a brand can activate audiences across brand-safe, streaming environments. This strategy enables meaningful engagement with prescribers while maintaining scale and compliance across CTV and complementary digital channels.
Cross-device activation for high-impact health campaigns
A biotech firm promoting a new therapy needs to reach patients who are likely to have a relevant condition, based on modeled audience segments. Using PurpleLab’s real-world patient segments, the advertiser activates across mobile, display, and CTV, with Experian’s identity graph ensuring household-level consistency across devices. Privacy and scale are preserved, while the brand ensures it’s not wasting impressions on ineligible or misaligned audiences.
Closed-loop measurement, built for healthcare
Beyond targeting, the PurpleLab–Experian integration empowers advertisers to measure real-world outcomes, not just digital proxies. By utilizing tokenization, Experian enables ad exposure data to be securely matched back to de-identified health events within PurpleLab’s platform.
This means marketers can assess outcomes such as:
- Prescription lift among exposed vs. unexposed audiences
- Healthcare professional engagement and treatment initiation
- Patient adherence or follow-through behavior
This type of closed-loop reporting is critical in pharma, where traditional metrics like clicks or impressions do not reflect business impact. Now, with token-based match-back, brands can see whether their campaigns are driving real results, securely and compliantly.
Ready to reach the right patients and providers securely and at scale?
Explore PurpleLab audiences in the Experian data marketplace and Audigent curated deals to activate clinically grounded, privacy-compliant segments across CTV, display, mobile, and more.
Contact us
Latest posts
CPG companies often base marketing decisions on custom market positioning studies, surveys and generic consumer personas. There’s a better way…
Study reveals that brands with more mature identity programs were significantly more likely to be successful in achieving their key objectives Tapad, a part of Experian, a global leader in cross-device digital identity resolution and a part of Experian, has commissioned Forrester Consulting, part of a leading research and advisory firm, to conduct a new study that evaluates the current state of customer data-driven marketing and explores how marketers can use identity solutions to deliver privacy safe and engaging experiences, in an evolving data landscape. The study highlights the changing ground rules for digital marketing and the threat that poses to marketers’ ability to deliver against long standing KPIs and campaign goals. Nearly two-thirds (62%) of respondents said that the forces of data deprecation will have a significant (40%) or critical (21%) impact on their marketing strategies over the next two years. Among those surveyed, identity resolution strategies have surfaced as an opportunity to create more powerful customer experiences, with 66% aiming to have it help improve customer trust and implement more ethical data collection and use practices, while nearly 60% believe it will point the way to more effective personalization and data management practices. Although organizations are eager to implement identity resolution strategies, a complex web of solutions and partners makes execution a challenge. For example, respondents report using at least eight identity solutions on average, across nearly six vendor partners, and they expect that fragmentation to persist in the ‘cookieless’ future. Additionally, brands’ identity resolution technologies typically represent a patchwork of homegrown and commercial solutions. Eighty-one percent of respondents use both in-house and commercial identity resolution tools today, and 47% use a near-equal blend of the two. Despite the challenges, many brands have the foundation for a strong identity resolution strategy in place, and they are thriving as a result. Specifically, more mature brands were 79% more successful at improving privacy safeguards to reduce regulatory and compliance risk, 247% more successful at improving marketing ROI, and over four times more effective at improving customer trust compared to their low-maturity peers. Additional insights include: Marketers Are Increasingly Playing a Key Strategic Role Within the Organization, But There is a Mandate to Demonstrate Value. Nearly three-quarters of respondents in our study agree the marketing function is more strategically important to their organization than it used to be, while almost two-thirds agree there’s more pressure than ever to prove the ROI or business performance of their activities. Consumers Expect Brands to Deliver Engaging Experiences Across Highly Fragmented Journeys: Tapad, a part of Experian found that 72% of respondents agree that customers demand more relevant, personalized experiences at the time and place of their choosing. At the same time, 67% of respondents recognize that customer purchase journeys take place over more touchpoints and channels than ever, and 59% of respondents agree that those journeys are less predictable and linear than they once were. Marketing Runs on Data, But the Rules Governing Customer Data Usage are Ever-Evolving: According to the study, 70% of decision-makers agree that consumer data is the lifeblood of their marketing strategies – fueling the personalized, omnichannel experiences customers demand. At the same time, 69% of respondents recognize that customers are increasingly aware of how their data is being used. At least two-thirds agree that data deprecation, including tighter restrictions on data use (66%), as well as operating system and browser changes impacting third-party cookies (68%) means that legacy marketing strategies are unlikely to remain viable in the long-term.“ Our latest survey findings give us a better understanding of how our customers and other companies around the world are trying to master the relationship between people, their data and their devices,” said Mark Connon, General Manager at Tapad, a part of Experian. “This research shows why it's fundamental for the industry to continuously work to develop solutions that are agnostic. Tapad, a part of Experian has worked tirelessly to deliver on this with our Tapad Graph, and by introducing solutions like Switchboard to help the evolving ecosystem and in turn helping customers reap the benefits of better identity in both short and long-term.” The study is founded on an online survey of over 300 decision-makers at global brands and agencies, which was fielded from March to April, 2021. Data deprecation and identity are fast-developing, moving targets, so this study delivers targeted insights and recommendations for how to prepare for coming shifts in customer data strategies – whether they manifest tomorrow or a year from now. Get in touch
With the recent announcement of delaying third-party cookie deprecation to 2024, the industry has more time to rethink how to identify and communicate with consumers.